Drawing for LIPOGEMS

USPTO serial 79187351

LIPOGEMS

Reviewed by CopyMark Law Group

Reg. 5193445Status 708Renewal
Filing date
Status date
Registration date
May 2, 2017
Examiner
O'BRIEN, JENNIFER LYNN
Law office
—

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with LIPOGEMS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Theodore R. Remaklus

Theodore R. Remaklus Thompson Hine LLP312 Walnut Street, Suite 2000Cincinnati, OH 45202United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceuticals, namely, pharmaceutical preparations for the treatment of wound healing, orthopedic conditions of joints, cartilage, tendons, ligaments and bones, soft tissue regeneration in dentistry, fecal and urinary incontinence, anal fistulas, Crohn's disease, pain management, inflammatory and immune conditions, oncology, neurology and neurodegenerative diseases and tissue-regenerative pharmaceutical preparations; pharmaceutical preparations and pharmaceutical substances for skin care; medicated pharmaceutical skin creams; pomades; cellular and tissue regenerative pharmaceutical preparations for the treatment of wound healing, orthopedic conditions of joints, cartilage, tendons, ligaments and bones, soft tissue regeneration in dentistry, fecal and urinary incontinence, anal fistulas, Crohn's disease, pain management, inflammatory and immune conditions, oncology, neurology and neurodegenerative diseases and tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for treatment and protection of damaged skin; adhesive skin and eye patches for medical purposes; transdermal patches featuring drugs for lipo reduction; sanitary preparations for medical use; pharmaceutical medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; medicated body creams; medicated moisturizing creams; medicated skin care creams; curative creams for wound healing, namely, wound dressing; disinfectants; antiseptic preparations; medicated preparations for skin care; liquid disinfectants and disinfectant gel for hygiene and sanitary purposes ]SECTION 71 - CANCELLED—
010Surgical apparatus and instruments; surgical apparatus and instruments for cellular and tissue regeneration; surgical apparatus and instruments for plastic and cosmetic surgery; surgical apparatus and instruments for plastic and cosmetic surgery for the treatment of adipose tissuesACTIVE—
041Provision of training activities, courses, seminars, conferences in the medical and surgical fieldsACTIVE—
044[ Medical and minimally invasive surgical services; regenerative medicine clinical services ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 2, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Oct 23, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Dec 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 26, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 26, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 26, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 26, 2024INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jul 31, 2024INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 31, 2024INPCINVALIDATION PROCESSED—
Jul 8, 2024INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Nov 7, 2023NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Nov 7, 2023C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Nov 7, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 6, 2023ES75TEAS SECTION 71 & 15 RECEIVED—
May 2, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 25, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 25, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 13, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 6, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 2, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 2, 2017FIMPFINAL DISPOSITION PROCESSED—
Aug 2, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 2, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 14, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 14, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 11, 2017GPNXNOTIFICATION PROCESSED BY IB—
Jan 25, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 25, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 25, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 5, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 15, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 15, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 15, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 15, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Dec 15, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 15, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 15, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 5, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 5, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 9, 2016RFNTREFUSAL PROCESSED BY IB—
Jun 22, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 22, 2016RFRRREFUSAL PROCESSED BY MPU—
Jun 17, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 16, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 8, 2016DOCKASSIGNED TO EXAMINER—
Jun 8, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance